The FDA has approved a generic form of fluticasone propionate inhalation aerosol (Flovent HFA) as a prophylactic maintenance treatment for asthma, the agency announced on Tuesday.
News-Medical.Net on MSN
Sustainable inhalers offer better outcomes for COPD patients
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...
Anoro Elipta may be better than Bevespi Aerosphere or Stiolto Respimat at lowering risk of chronic obstructive pulmonary lung disease flares.
There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results